Publications by authors named "Niccolo Bitto"

Claim this Profile
O
Overview of gene therapy for hemophilia: questions and answers to navigate the innovation.
Pascal Hoffmann, Niccolò Bitto, Vincenzo La Mura, Wolfgang Miesbach

J Thromb Haemost· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene Therapy for Hemophilias: Opportunities and Challenges for the Clinical Laboratory.
Armando Tripodi, Isabella Garagiola, Niccolò Bitto, Vincenzo La Mura, Flora Peyvandi

Clin Chem· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Challenging Case of Immune-Related Organizing Pneumonitis Following Programmed Cell Death 1 Inhibitor Therapy in Non-Small Cell Lung Cancer.
Giovanni Paolozzi, Roberta Gualtierotti, Raffaella Rossio, Barbara Ferrari, Niccolo Bitto

J Clin Med Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome.
Marta Magaz, Heloïse Giudicelli-Lett, Juan G Abraldes, Oana Nicoară-Farcău, Fanny Turon, Niccolò Bitto

J Hepatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene therapy in hemophilia: the dawn of a new era.
Roberta Gualtierotti, Andrea Giachi, Niccolò Bitto, Vincenzo La Mura, Flora Peyvandi

Res Pract Thromb Haemost· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual burden of liver disease after HCV clearance in hemophilia: a word of caution in the era of gene therapy.
Vincenzo La Mura, Niccolò Bitto, Cecilia Capelli, Camilla Caputo, Simona Siboni

Blood Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome.
Marta Magaz, Heloïse Giudicelli-Lett, Oana Nicoară-Farcău, Neil Rajoriya, Ashish Goel, Niccolò Bitto

Transplantation· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis.
Niccolò Bitto, Gabriele Ghigliazza, Stanislao Lavorato, Camilla Caputo, Vincenzo La Mura

J Clin Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges.
Vincenzo La Mura, Niccolò Bitto, Armando Tripodi

Expert Rev Hematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of Endotoxemia.
Vincenzo La Mura, Nicoletta Gagliano, Francesca Arnaboldi, Patrizia Sartori, Patrizia Procacci, Niccolò Bitto

Cells· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AB0, von Willebrand factor/factor VIII and portal vein thrombosis in decompensated cirrhosis: Too late to unmask the culprit?
Niccolò Bitto, Giulia Tosetti, Vincenzo La Mura, Massimo Primignani

Liver Int· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
Vincenzo La Mura, Simon Braham, Giulia Tosetti, Federica Branchi, Niccolò Bitto

Clin Gastroenterol Hepatol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coagulation, Microenvironment and Liver Fibrosis.
Niccolò Bitto, Eleonora Liguori, Vincenzo La Mura

Cells· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coagulation and fibrosis: A potential non-negligible target of statins in chronic hepatitis.
Niccolò Bitto, Francesco Salerno, Armando Tripodi, Vincenzo La Mura

J Hepatol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis